514 Episodes

  1. S8 Ep49: Andreeff Sheds Light on the Evaluation of the E-selectin Antagonist Uproleselan in AML

    Published: 5/29/2023

  2. S8 Ep48: Gottschalk and Krenciute Discuss the Development of CAR T-cell Therapy in Pediatric Solid Tumors 

    Published: 5/25/2023

  3. S8 Ep47: Mutale Discusses Disparities in Cancer Clinical Trial Eligibility, Access and Enrollment

    Published: 5/22/2023

  4. S8 Ep46: Oncology Professionals Explain the Nuances of Career-Building Mentorship and Self-Advocacy

    Published: 5/18/2023

  5. S8 Ep45: FDA Approval Insights: Omidubicel in Blood Cancers Requiring Transplant

    Published: 5/15/2023

  6. S8 Ep44: Haffner Highlights Treatment and Research Considerations for Basal Cell Carcinoma of the Prostate

    Published: 5/11/2023

  7. S8 Ep43: Ehrhardt Explains the Effects of Modifiable Health Conditions on Late Mortality for Childhood Cancer Survivors

    Published: 5/8/2023

  8. S8 Ep41: Stand Up to Cancer Grant Recipients Discuss Initiative to Expand Access to Early-Phase Clinical Trials

    Published: 5/1/2023

  9. S8 Ep40: Kim Discusses the Development of LP-300 Plus Chemotherapy in Advanced Lung Cancer

    Published: 4/27/2023

  10. S8 Ep39: FDA Approval Insights: Enfortumab Vedotin Plus Pembrolizumab in Urothelial Carcinoma

    Published: 4/24/2023

  11. S8 Ep38: Gushchin and Diaz-Montes Describe QOL Outcomes After Cytoreduction and HIPEC in Ovarian Cancer

    Published: 4/20/2023

  12. S8 Ep37: Desai Discusses the Significance of a Supportive, Foundational Fellowship Experience

    Published: 4/17/2023

  13. S8 Ep36: FDA Approval Insights: Dostarlimab in dMMR Advanced Endometrial Cancer

    Published: 4/13/2023

  14. S8 Ep35: Gynecologic Cancer Experts Review 2023 SGO Research and Treatment Updates

    Published: 4/10/2023

  15. S8 Ep34: Mercado and Kovacs Emphasize the Importance of Multidisciplinary Lung Cancer Screening and Management

    Published: 4/6/2023

  16. S8 Ep33: Kishan Discusses GI Toxicity Reduction With MRI-Guided SBRT in Prostate Cancer

    Published: 4/3/2023

  17. S8 Ep32: FDA Approval Insights: Elacestrant in ER+/HER2– ESR1-mutated Advanced or Metastatic Breast Cancer

    Published: 3/30/2023

  18. S8 Ep31: Breast Cancer Experts Review 2023 MBCC Research Updates and the Importance of Multidisciplinary Collaboration

    Published: 3/27/2023

  19. S8 Ep29: FDA Approval Insights: Sacituzumab Govitecan in HR-positive, HER2-negative Breast Cancer

    Published: 3/20/2023

  20. S8 Ep28: Raez Reports Benefits of Liquid Biopsy in Newly Diagnosed NSCLC

    Published: 3/16/2023

17 / 26